Lung and Thymic Neuroendocrine Tumors

Clinical Endocrine Oncology: Second Edition

Volumn , Issue , 2009, Pages 482-487

  Granberg, Dan ^a   Öberg, Kjell ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetic alterations; Histopathology and immunohistochemistry; Multiple endocrine neoplasia type 1 syndrome; Neuroendocrine lung tumors (bronchial carcinoids); Thymic neuroendocrine tumors (carcinoids) (TNETS)

Indexed keywords

EID: 84889392722     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300222.ch64     Document Type: Chapter

References (22)

1. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Countries ICwLHSaPf. Histological Typing of Lung and Pleural Tumours, 3rd edition. Berlin: Springer, World Health Organization, 1999.
2. Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer 1972; 29:1061-1074.
3. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13 715 carcinoid tumors. Cancer 2003; 97:934-959.
4. Warren WH, Memoli VA, Gould VE. Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. I. Carcinoids. Ultrastruct. Pathol. 1984; 6:15-27.
5. McCaughan BC, Martini N, Bains MS. Bronchial carcinoids-review of 124 cases. J. Thorac. Cardiovasc. Surg. 1985; 89:8-17.
6. Bertelsen S, Aasted A, Lund C, et al. Bronchial carcinoid tumors-a clinicopathologic study of 82 cases. Scand. J. Thorac. Cardiovasc. Surg. 1985; 19:105-111.
7. Granberg D, Sundin A, Janson ET, Öberg K, Skogseid B, Westlin J-E. Octreoscan in patients with bronchial carcinoid tumours. Clin. Endocrinol. 2003; 59:793-799.
8. Örlefors H, Sundin A, Garske U, et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors-comparison with somatostatin receptor scintigraphy and computed tomography. J. Clin. Endocrinol. Metab. 2005; 90:3392-3400.
9. Aslan DL, Gulbahce HE, Pambuccian SE, Manivel JC, Jessurun J. Ki-67 immunoreactivity in the differential diagnosis of pulmonary neuroendocrine neoplasms in specimens with extensive crush artifact. Am. J. Clin. Pathol. 2005; 123:874-878.
10. Granberg D, Eriksson B, Wilander E, et al. Experience in treatment of metastatic pulmonary carcinoid tumors. Ann. Oncol. 2001; 12:1383-1391.
11. Granberg D, Wilander E, Öberg K. Expression of tyrosine kinase receptors in lung carcinoids. Tumor Biol. 2006; 27:153-157.
12. Schrevens L, Vansteenkiste J, Deneffe G, et al. Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience. Lung Cancer 2004; 43:39-45.
13. Chughtai TS, Morin JE, Sheiner NM, Wilson JA, Mulder DS. Bronchial carcinoid-twenty years' experience defines a selective surgical approach. Surgery 1997; 122:801-808.
14. Granberg D, Wilander E, Öberg K, Skogseid B. Prognostic markers in patients with typical bronchial carcinoid tumors. J. Clin. Endocrinol. Metab. 2000; 85:3425-3430.
15. Dusmet ME, McKneally MF. Pulmonary and thymic carcinoid tumors. World J. Surg. 1996; 20:189-195.
16. Teh BT. Thymic carcinoids in multiple endocrine neoplasia type 1. J. Intern. Med. 1998; 243:501-504.
17. Fukai I, Masaoka A, Fujii Y, et al. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann. Thorac. Surg. 1999; 67:208-211.
18. Filosso PL, Actis Dato GM, Ruffini E, Bretti S, Ozzello F, Mancuso M. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. J. Thorac. Cardiovasc. Surg. 2004; 127:1215-1219.
19. Ferolla P, Falchetti A, Filosso P, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J. Clin. Endocrinol. Metab. 2005; 90:2603-2609.
20. Ferone D, van Hagen MP, Kwekkeboom DJ, et al. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro. J. Clin. Endocrinol. Metab. 2000; 85:1719-1726.
21. Eriksson B, Bergstrom M, Sundin A, et al. The role of PET in localization of neuroendocrine and adrenocortical tumors. Ann. N. Y. Acad. Sci. 2002; 970:159-169.
22. Ekeblad S, Sundin A, Janson ET, et al. Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Clin. Cancer Res. 2007; 13:2986-2991.